AHF Sierra Leone

21/09/2026

HIV is not the death sentence it once was. With consistent access to treatment, people living with HIV can live long, full lives – raising families, building careers, and planning for the future.

But that promise only holds if treatment reaches everyone who needs it. Right now, gaps in testing and treatment coverage mean too many people are still being left behind.

Governments and health systems must prioritize HIV testing and treatment coverage in national health policy and budgets because access to treatment is access to life.

TREATMENT = LIFE. Let's make sure everyone gets the chance to live theirs.

14/09/2026

What we are witnessing in the PABS negotiations at the World Health Organization is fundamentally at odds with the right to science.
The right to science is not simply about a right to access scientific knowledge. It encompasses everyone's right to participate in scientific progress and to enjoy its benefits.
In the post-war debates that helped shape the right to science, there was recognition that intellectual property protections should not be permitted to create monopolies that prevent people from sharing in the benefits of scientific progress.
Nearly eighty years later, the same fundamental question is before us.
In the PABS negotiations, developing countries are being asked to provide the pathogen samples and sequence information that make scientific progress possible. Yet the European Union, Norway, Japan and Switzerland are resisting legally binding contracts at the point of access that would ensure that recipients of pathogen samples and sequences are legally bound to share benefits generated from having access to such resources.
A fair and effective PABS System must do more than facilitate access to scientific information. It must ensure that developing countries have guarantees to fair and equitable benefit sharing such as rapid access to medicines, vaccines and diagnostics, licensing for rapidly scaling up production and expanding supply options — while also enabling them to build their scientific, technological and productive capacity.
When the benefits of scientific progress are shared fairly and equitable, the right to science is truly realized. The European Union, Norway, Japan and Switzerland must stop obstructing developing countries’ right to participate in and benefit from scientific progress.

12/08/2026

Investing in young people is investing in a healthier future. 🌍❤️

In 2024, 370,000 young people ages 15–24 acquired HIV globally, including 145,000 adolescents ages 15 to 19, and 93,000 children ages 14 and younger acquired HIV in 2025. Yet as health budgets shrink, the programs and services young people need are increasingly at risk.

We already know what works: youth-friendly HIV and sexual and reproductive health services, comprehensive sexuality education, and safe spaces where young people can learn, ask questions, and be heard.

Through programs like Girls Act and Boys2Men, AHF is helping young people access knowledge, build supportive peer networks, and become advocates for healthier communities.

This , we’re calling for continued investment in young people—and a future where every young person has the knowledge, resources, and support they need to thrive.

20/05/2026

❤️ 3 MILLION lives in care. 🌍

This milestone is more than a number. It represents 3 million people living with HIV whose lives have been transformed by care, compassion, and the belief that healthcare is a human right. ✨

This milestone belongs to our staff, partners, and clients across our 50 country teams, and we extend our deepest gratitude to everyone whose dedication made it possible. 🙌

The HIV epidemic is not over. But 3 million lives in care shows what’s possible when urgency, persistence, and compassion come together. 💪❤️

Onward to 5 million by 2030. 🚀

21/03/2026

As part of a global movement for a binding Annex to the , global public health advocates hit the streets in Brussels on March 18.

Led by AHF Europe, alongside partners G*T, @ Positive Voice, and Demetra, the protest at headquarters sent a clear message to EU leaders: No Equity, No Deal!

European Commission World Health Organization (WHO) Public Citizen

Watch here 👇

Global public health advocates protest at European Commission headquarters in Brussels on March 18, 2026, demanding that European powers support a legally bi...

20/03/2026

17/03/2026

📊 Transparency matters in the WHO Pandemic Agreement negotiations.

Decisions about who receives vaccines and treatments during a health crisis should be based on public health needs—not politics.

The EU: Stop Blocking Health Equity campaign calls for transparent, accountable rules in the Annex to ensure fairness.

17/03/2026

🤝 A key principle in the WHO Pandemic Agreement negotiations:

Cooperation, not extraction.

If companies use pathogen samples and data to develop vaccines or treatments, they must contribute back to the global system that made those discoveries possible.

Through our EU: Stop Blocking Health Equity campaign, advocates are urging EU leaders to support mandatory benefit-sharing in the Annex.

16/03/2026

🏭 The WHO Pandemic Agreement PABS Annex also aims to strengthen regional manufacturing.

Technology transfer and licensing can help ensure vaccines and treatments are produced in multiple regions during future health crises.

Through the EU: Stop Blocking Health Equity campaign, advocates are urging EU leaders to support these equity measures in the negotiations.

16/03/2026

🧬 Countries around the world share pathogen samples that help scientists develop vaccines and medicines.

But under the current system, those same countries are not guaranteed fair access to the tools developed using their data.

The WHO Pandemic Agreement PABS negotiations must fix this.

The campaign EU: Stop Blocking Health Equity is calling on EU leaders to support fair and enforceable benefit-sharing rules.